Lee Wendy Y, Capra Angela M, Jensvold Nancy G, Gurwitz Jerry H, Go Alan S
Division of Research, Kaiser Permanente of Northern California, Oakland, California 94612-2304, USA.
Am J Cardiol. 2004 Nov 1;94(9):1147-52. doi: 10.1016/j.amjcard.2004.07.081.
Congestive heart failure (CHF) is the leading cause of hospitalization in the elderly, and these patients are at high risk for subsequent hospitalization. Whether gender affects the risk of rehospitalization in patients who have CHF is less well understood. We studied a random sample of 1,700 adults who had been hospitalized with CHF (from July 1, 1999 to June 30, 2000) and identified all readmissions through June 30, 2001. We used proportional hazards regression to evaluate whether gender affects the risk of all-cause and CHF-specific rehospitalization, after adjusting for differences in demographic characteristics, health-related behaviors, co-morbid conditions, left ventricular systolic function status, and use of CHF therapies. Among 1,591 adults who had confirmed CHF, 752 were women (47.3%). Women were older than men (73 vs 71 years, p <0.001) and more likely to have preserved systolic function (55.3% vs 40.9%, p <0.001), hypertension (83.1% vs 75.2%, p <0.001), and prior renal insufficiency (46.8% vs 34.6%, p <0.001). No significant differences existed between women and men with respect to crude rates of any readmission (144.7 vs 134.6 per 100 person-years, p = 0.36) or CHF-specific readmission (39.9 vs 37.4 per 100 person-years, p = 0.65). After adjusting for potential confounders, there was no significant difference between women and men with respect to risk of any readmission (adjusted hazard ratio 0.88, 95% confidence interval 0.76 to 1.02) or readmission for CHF (adjusted hazard ratio 0.89, 95% confidence interval 0.71 to 1.11). Among a contemporary, diverse population of patients who had CHF, rates of readmission overall and for CHF remained high, but gender was not independently associated with a differential risk of readmission.
充血性心力衰竭(CHF)是老年人住院治疗的主要原因,这些患者再次住院的风险很高。性别是否会影响CHF患者再次住院的风险,目前还不太清楚。我们研究了1700名因CHF住院的成年人的随机样本(从1999年7月1日至2000年6月30日),并确定了截至2001年6月30日的所有再次入院情况。在调整了人口统计学特征、健康相关行为、合并症、左心室收缩功能状态以及CHF治疗方法的差异后,我们使用比例风险回归来评估性别是否会影响全因和CHF特异性再次住院的风险。在1591名确诊为CHF的成年人中,752名是女性(47.3%)。女性比男性年龄更大(73岁对71岁,p<0.001),更有可能保留收缩功能(55.3%对40.9%,p<0.001)、患有高血压(83.1%对75.2%,p<0.001)和既往肾功能不全(46.8%对34.6%,p<0.001)。在任何再次入院的粗发病率方面(每100人年144.7次对134.6次,p = 0.36)或CHF特异性再次入院方面(每100人年39.9次对37.4次,p = 0.65),女性和男性之间没有显著差异。在调整潜在混杂因素后,女性和男性在任何再次入院风险方面(调整后的风险比为0.88,95%置信区间为0.76至1.02)或因CHF再次入院风险方面(调整后的风险比为0.89,95%置信区间为0.71至1.11)没有显著差异。在当代多样化的CHF患者群体中,总体再次入院率和CHF再次入院率仍然很高,但性别与再次入院的差异风险没有独立关联。